secwatch.observer — SEC 8-K summary
======================================

Issuer:     Opus Genetics, Inc. (IRD)
CIK:        0001228627
Form:       8-K
Filed at:   2025-05-01T23:59:59+00:00
Accession:  0001140361-25-016948
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Opus Genetics stockholders elect nine directors and approve all proposals at 2025 annual meeting
--------------------------------------------------------------------------------

- All nine director nominees elected with >21M votes for each; no withhold votes exceeded 3.1M.
- Ratification of Ernst & Young as auditor for FY2025 passed with 30.2M votes for (94% of votes cast).
- Advisory say-on-pay proposal approved with 20.4M votes for (86% of votes cast).
- Conversion of Series A Preferred Stock into common stock approved with 16.7M votes for (84% of votes cast).
- Adjournment proposal passed but deemed moot as Conversion proposal already passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1228627/000114036125016948/0001140361-25-016948-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1228627/000114036125016948/ef20048353_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-016948

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer